In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells.
about
In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro long-term treatment w ...... ng sensitivity to CD8 T cells.
@en
In vitro long-term treatment w ...... ng sensitivity to CD8 T cells.
@nl
type
label
In vitro long-term treatment w ...... ng sensitivity to CD8 T cells.
@en
In vitro long-term treatment w ...... ng sensitivity to CD8 T cells.
@nl
prefLabel
In vitro long-term treatment w ...... ng sensitivity to CD8 T cells.
@en
In vitro long-term treatment w ...... ng sensitivity to CD8 T cells.
@nl
P2093
P2860
P356
P1433
P1476
In vitro long-term treatment w ...... ing sensitivity to CD8 T cells
@en
P2093
Antonela Barón
Erika María von Euw
José Mordoh
P2860
P304
P356
10.3892/OR.2017.5363
P577
2017-01-13T00:00:00Z